Ingredient

Human Umbilical Mesenchymal Stem Cell Conditioned Media

Human Umbilical Mesenchymal Stem Cell Conditioned Media is flagged for pregnancy, breastfeeding, trying to conceive, postpartum, PCOS and general use. The concern behind the strongest flag is absorbed into the body and fetal development.

By Team TruvaLast checked

Verdict by profile

Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.

Strongest verdict
Not Recommended
Its verdict for pregnancy, the profile this one is worst in
Profiles flagged
6 of 6
Counting avoid, high risk and medium risk
Irritancy
1 of 5
Higher means more likely to sting or redden
PregnancyAVOID

Human Umbilical Mesenchymal Stem Cell Conditioned Media and pregnancy

Not Recommended

Human umbilical mesenchymal stem cell conditioned media contains biologically active growth factors, cytokines, and signaling proteins that stem cells secrete during culture. In cosmetics, these proteins are intended to promote skin regeneration and reduce signs of aging by stimulating cellular repair processes. The primary concern during pregnancy is the complete lack of safety data for topical use of human-derived growth factors. Growth factors are biologically active molecules that influence cell proliferation and differentiation. While topical absorption of large proteins is generally limited, some growth factors may penetrate the skin barrier. Given their potent biological activity and unknown effects on fetal development, most obstetricians would recommend avoiding these novel biotechnology ingredients during pregnancy as a precautionary measure. No regulatory body has issued specific guidance on stem cell conditioned media use during pregnancy. The lack of clinical studies, combined with the theoretical risk that growth factors could affect cellular development, leads to a conservative recommendation. Most dermatologists advise pregnant women to postpone use of experimental or poorly studied cosmetic ingredients until after delivery.

BreastfeedingAVOID

Human Umbilical Mesenchymal Stem Cell Conditioned Media and breastfeeding

Not Recommended

While proteins and growth factors in stem cell conditioned media are typically too large to pass significantly through intact skin, facial application could result in inadvertent oral exposure through normal contact with an infant during breastfeeding (hand-to-mouth, kissing, etc.). The complete absence of safety data for infant exposure to these biotechnology-derived ingredients creates uncertainty. Growth factors are potent signaling molecules, and their effects on infant development have not been studied. Additionally, the human-derived nature of the ingredient raises theoretical concerns about immune sensitization in infants. Without established safety profiles or regulatory guidance, most lactation consultants and dermatologists recommend avoiding novel biotechnology ingredients during breastfeeding. The risk-benefit ratio favors choosing well-studied alternatives with known safety profiles for this sensitive period.

PostpartumCAUTION

Human Umbilical Mesenchymal Stem Cell Conditioned Media and postpartum

Caution Advised

For women who are not breastfeeding, stem cell conditioned media may offer potential benefits for addressing postpartum skin concerns such as stretch marks, loss of elasticity, and dullness. The growth factors and proteins in the ingredient theoretically support skin repair and collagen production. The medium risk rating reflects the lack of long-term safety studies and potential for allergic reactions to human-derived proteins. While direct fetal or infant exposure is not a concern, the ingredient's novelty and limited regulatory oversight warrant caution. Those with sensitive skin or immune concerns should patch test carefully and consider consulting a dermatologist before use.

Trying to ConceiveAVOID

Human Umbilical Mesenchymal Stem Cell Conditioned Media and trying to conceive

Not Recommended

Women trying to conceive should treat their preconception period similarly to early pregnancy, as conception timing is often uncertain. Stem cell conditioned media lacks any safety data for use during the periconception period or early embryonic development. The biologically active nature of growth factors raises theoretical concerns about effects on cellular processes during the critical early stages of pregnancy. Most fertility specialists recommend discontinuing novel, unstudied cosmetic ingredients when actively trying to conceive, adopting a 'better safe than sorry' approach to protect potential early pregnancy.

PCOSCAUTION

Human Umbilical Mesenchymal Stem Cell Conditioned Media and PCOS

Caution Advised

Women with PCOS often struggle with acne, inflammation, and premature aging due to hormonal imbalances. Stem cell conditioned media contains anti-inflammatory cytokines and growth factors that could theoretically benefit these skin concerns without directly affecting hormone levels. The concern lies in the unknown interaction between growth factors and the already-disrupted endocrine system in PCOS. Growth factors like IGF-1 and EGF can influence cellular signaling pathways that intersect with insulin and androgen metabolism. While topical application is unlikely to cause systemic hormonal effects, the lack of specific research in women with hormonal disorders creates uncertainty. No studies have examined stem cell conditioned media safety or efficacy specifically in PCOS populations. Given the metabolic and hormonal complexities of this condition, women with PCOS may prefer to choose well-studied ingredients with clearer safety profiles, particularly if they are also managing fertility concerns or taking hormonal medications.

General UseCAUTION

Human Umbilical Mesenchymal Stem Cell Conditioned Media and general use

Caution Advised

For the general adult population, stem cell conditioned media represents an innovative but incompletely studied cosmetic ingredient. It contains various growth factors, cytokines, and proteins that may support skin regeneration, collagen production, and anti-aging benefits. Some small studies and anecdotal reports suggest improvements in skin texture and appearance. The primary concerns are the lack of standardized manufacturing processes, limited long-term safety data, and potential for allergic reactions to human-derived proteins. The FDA does not require pre-market approval for cosmetic ingredients, meaning quality control depends entirely on individual manufacturers. Additionally, individuals with autoimmune conditions or heightened immune sensitivity may be at increased risk for adverse reactions. The EU Cosmetics Regulation permits human cell-derived ingredients but lacks specific testing requirements for this novel category. Most dermatologists recommend patch testing before use and purchasing from reputable brands with transparent sourcing and processing. Those seeking similar benefits may prefer established peptide complexes or plant-derived growth factor alternatives with more robust safety profiles.

Same profiles

Everything else flagged for the same profiles

Keep reading

Related ingredients

Ingredients suggested in place of Human Umbilical Mesenchymal Stem Cell Conditioned Media, each one with its own page here.

Ingredients that raise the same concerns.

Provenance

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on .

One ingredient is the easy case.

A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.

Download on theApp Store